HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk Patients
The objective of this study is to observe the preventive effects of high flow nasal oxygenation on the incidence of hypoxia during gastroscopy or colonoscopy sedated with propofol in high-risk patients.
Gastric Cancer|Intestinal Cancer|Intestine Adenoma|Gastritis
DEVICE: High-flow nasal cannula oxygenation|DEVICE: Regular nasal cannula oxygenation
The incidence of hypoxia, Hypoxia refers to 75%≤SpO2\<90%,\<60S, Patients will be followed for the duration of hospital stay, an expected average of 2 hours
The incidence of severe hypoxia, Severe hypoxia refers to SpO2\<75% lasting for any time, or 75%≤SpO2\<90%, ≥60s, Patients will be followed for the duration of hospital stay, an expected average of 2 hours|The incidence of subclinical respiratory depression, Subclinical respiratory depression refers to 90%≤ SpO2\<95%, Patients will be followed for the duration of hospital stay, an expected average of 2 hours|Other adverse events evaluated by the tool of World SIVA, Patients will be followed for the duration of hospital stay, an expected average of 2 hours|Complications related to high-flow nasal cannula, Patients will be followed for the duration of hospital stay, an expected average of 2 hours
The objective of this study is to observe the preventive effects of high flow nasal oxygenation on the incidence of hypoxia during gastroscopy or colonoscopy sedated with propofol in high-risk patients.